ArticleApplied microbiology and biotechnology2026
B-vitamin supplementation unlocks DHA production of Aurantiochytrium limacinum on molasses-based fermentation residue.
Article in Applied microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Various marine protists inhabiting high-salinity environments can convert organic nutrients into high-value biomolecules or biomass, making them suitable agents for valorizing saline organic residue from fermentation waste streams, such as condensed molasses fermentation solubles (CMS). This study established a screening method to identify mixotrophic or heterotrophic marine protists suitable for CMS valorization and to assess their bioconversion potential. Growth-performance and nutrient-replacement assays were evaluated based on relative colony coverage on agar plates and final cell density in liquid culture. When applied to the selected strain, Aurantiochytrium limacinum, CMS supplementation was shown to enhance glucose consumption and biomass production; however, it did not increase the production of fatty acids such as docosahexaenoic acid (DHA). Reducing medium salinity did not rescue the impaired lipid biosynthesis, whereas supplementation with vitamins B1, B7, and B12 restored fatty acid production in a dose-dependent manner. These results indicate that vitamin-associated cofactors are major determinants of fatty acid biosynthesis under CMS-based cultivation. Our findings demonstrate that molasses-derived residues can serve as substrates for the production of highly unsaturated fatty acids. They also provide evidence that B-vitamin cofactors play an important role in the fatty acid biosynthetic pathway of thraustochytrids. KEY POINTS: • CMS supported robust growth but did not promote proportional lipid synthesis in Aurantiochytrium limacinum. • B-vitamin insufficiency (B₁, B₇, and B₁₂) was identified as the primary factor limiting the biosynthesis of fatty acids. • Supplementation with B-vitamin cofactors restored fatty-acid and DHA biosynthesis in a dose-dependent manner.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.